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Cellular thiols such as cysteine spontaneously and readily
react with the respiratory intermediate fumarate, resulting in
the formation of stable S-(2-succino)-adducts. Fumarate-medi-
ated succination of thiols increases in certain tumors and in
response to glucotoxicity associated with diabetes. Therefore,
S-(2-succino)-adducts such as S-(2-succino)cysteine (2SC) are
considered oncometabolites and biomarkers for humandisease.
No disposal routes for S-(2-succino)-compounds have been
reported prior to this study. Here, we show thatBacillus subtilis
metabolizes 2SC to cysteine using a pathway encoded by the yxe
operon. The first step is N-acetylation of 2SC followed by an
oxygenation that we propose results in the release of oxaloace-
tate andN-acetylcysteine, which is deacetylated to give cysteine.
Knockouts of the genes predicted to mediate each step in the
pathway lose the ability to grow on 2SC as the sulfur source and
accumulate the expected upstream metabolite(s). We further
show thatN-acetylation of 2SC relieves toxicity. This is the first
demonstration of a metabolic disposal route for any S-(2-suc-
cino)-compound, paving the way toward the identification of
corresponding pathways in other species.
The respiratory intermediate fumarate, an electrophilic ,-
unsaturated dicarboxylate, reacts spontaneously and readily
with soft nucleophiles such as sulfhydryl groups in a process
known as succination (1, 2). Fumarate and the sulfhydryl group
of cysteine undergo succination to form the stable compound
S-(2-succino)cysteine (2SC),3 which exists as two diastereom-
ers due to the chirality of the S-(2-succino) bond; this reaction
can occur with free cysteine as well as with cysteinyl residues of
proteins and small-molecule thiols such as GSH (1, 2) (Fig. 1).
Succination of proteins and GSH is biologically significant due
to their high cellular concentrations and because their cysteinyl
residues can be significantly more acidic (and hence nucleo-
philic) than free cysteine (1, 2). Cysteine residues located in
enzyme active sites are likely to exist as strongly nucleophilic
thiolate anions (3), making thiol enzymes particularly prone to
succination (4). Several proteins with functional cysteine resi-
dues are known to be susceptible to succination that results in
impaired functionality, including glyceraldehyde-3-phosphate
dehydrogenase (5, 6), aconitase (7), actin and tubulin (8, 9), and
chaperone proteins (9). At least 182 succinated proteins have
been detected in humans (10). Succination is thus a common
and well-described post-translational chemical modification of
proteins.
The degree of succination of biological thiols is directly
related to fumarate concentration (1). Accordingly, 2SC can
serve as a biomarker for abnormalities in aerobic respiration
that cause fumarate buildup. In humans, germline mutations
that inactivate the citric acid cycle enzyme fumarate hydratase
cause fumarate accumulation and increase the succination of
cellular thiols; such mutations predispose to hereditary leio-
myomatosis and renal cell cancer syndrome (11–13). 2SC is
considered an oncometabolite because of its accumulation in
certain cancers (14). An increase in succination due to fumarate
accumulation is also observed in adipose tissue under the
hyperglycemic conditions associated with type 2 diabetes and
obesity (15–17). Succination of proteins has many deleterious
effects (18–21). Additionally, succination of GSH can lead to
persistent oxidative stress and cellular senescence (22). The
harmful effects of succination suggest that this process is more
than just a symptom of mitochondrial stress or dysfunction in
chronic diseases but that succination actually contributes to the
pathogenesis of disease complications. In support of this,
recent studies suggest that succination is the mechanistic link
between mitochondrial and endoplasmic reticulum complica-
tions in diabetes (23).
Much research has focused on targets of succination and the
role of succination in disease but not on the metabolism of 2SC
after it forms. Nometabolic disposal route for 2SC has yet been
demonstrated. Here, we present biochemical and genetic
analyses showing that Bacillus subtilis has a breakdown
pathway that is specific for 2SC. These analyses implicate the
yxe operon in 2SC breakdown, show that the pathway begins
with acetylation and ends with deacetylation, and confirm
that 2SC is toxic.
This work was supported by National Science Foundation Grant MCB-
1153413 and by an endowment from the C. V. Griffin Sr. Foundation. The
authors declare that they have no conflicts of interest with the contents of
this article.
This article contains Figs. S1–S5 and Tables S1 and S2.
1 To whom correspondence may be addressed: Horticultural Sciences Dept.,
University of Florida, 1301 Fifield Hall, 2550 Hull Rd., Gainesville, FL 32611.
Tel.: 352-273-4856; Fax: 352-392-5653; E-mail: tomniehaus@ufl.edu.
2 To whom correspondence may be addressed: Horticultural Sciences Dept.,
University of Florida, 1301 Fifield Hall, 2550 Hull Rd., Gainesville, FL 32611.
Tel.: 352-273-4856; Fax: 352-392-5653; E-mail: adha@ufl.edu.
3 The abbreviations used are: 2SC, S-(2-succino)cysteine; NAC, N-acetyl-L-cys-
teine; Tn-seq, transposon sequencing.
croARTICLE
J. Biol. Chem. (2018) 293(21) 8255–8263 8255
© 2018 Niehaus et al. Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc.
 at N
ew
 Y
ork M
edical College on N
ovem
ber 6, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Results
B. subtilis uses 2SC as a sulfur source
We first tested whether Escherichia coli or B. subtilis can uti-
lize 2SC as the sulfur source. 2SC served as an excellent sulfur
source for B. subtilis but not E. coli (Fig. S1). A cysteine aux-
otroph of B. subtilis (yrhA cysK) (24) also grew well on 2SC
(Fig. S2), demonstrating that B. subtilis can metabolize 2SC to
cysteine.
A high-throughput screen implicates the yxe operon in 2SC
utilization
To identify the gene(s) required tometabolize 2SC, we used a
high-throughput screen with a B. subtilis library containing
7.3  104 unique magellan6x transposon insertions (i.e. Tn-
seq) (25). The initial transposon-mutant population was grown
for six generations on defined medium containing 2SC, sulfate,
or methionine as the sulfur source. Afterward, the transposon
insertion sites were sequenced, allowing us to map the location
and relative frequency of each transposon insertion for each
experiment. If a gene is important for growth on one particular
sulfur source, then the relative frequency of transposon inser-
tions located within that gene will decrease in the population
grown on that sulfur source relative to the others. Different
transposon insertions can result in varying degrees of gene
silencing, so a gene may still contain transposons even if it is
essential under a certain growth condition.
Sulfate- or methionine-grown populations served as both
controls and comparisons for the 2SC-grown population. As
expected, nearly every gene involved in cysteine and methio-
nine synthesis was essential when grown on sulfate but not
when grown on methionine (Fig. S3). Because B. subtilis can
metabolize 2SC to cysteine (Fig. S2), growing cells on 2SC is
functionally equivalent to growing cells on cysteine. Accord-
ingly, genes involved in the conversion of cysteine to methio-
ninewere essential when grown on 2SC (Fig. S3). Observing the
expected trends in the different sulfur-source populations val-
idated the screening procedure. The only genes that signifi-
cantly affected fitness in the 2SC-grown population but not in
either sulfate- or methionine-grown populations were genes of
the yxe operon (Fig. 2), particularly yxeK and yxeL.
The yxe operon and its distribution
The yxe operon consists of seven genes that encode a pre-
dicted FAD-dependent monooxygenase, yxeK; an acetyltrans-
ferase, yxeL; three components of an ATP-transporter com-
plex, yxeMNO; an N-acetylcysteine deacetylase, yxeP; and a
putative dehydratase, yxeQ. No specific role for the yxe operon
has been ascribed, but there is evidence that the acetyltrans-
ferase yxeL and N-acetylcysteine deacetylase yxePmay partici-
pate in the degradation of S-methylcysteine, and they have been
named snaB and sndB, respectively (26). Here, we retain yxe
designations. The yxe operon is widely distributed in bacteria,
occurring in firmicutes and -, -, and -proteobacteria (Fig.
S4). E. coli lacks both the yxe operon and the ability to use 2SC
as a sulfur source (Fig. S2). A priori, it is reasonable to predict
that the yxe operon plays a role in 2SC metabolism.
Analysis of mutants confirms a role for yxe genes in 2SC
metabolism
Because Tn-seq indicated that yxe operon genes play a role in
2SC metabolism, we obtained a BKE knockout mutant (27) for
each of the yxe operon genes and tested the mutants’ ability
to grow on 2SC as the only sulfur source. Deletants of the
monooxygenase yxeK and the acetyltransferase yxeL were
severely limited in their ability to grow on 2SCwith only a slight
trace of growth observed for either mutant (Fig. 3A). In con-
trast, no obvious growth defect was observed for the other yxe
gene deletants (Fig. 3A).
The acetyltransferase YxeL has a homolog in B. subtilis,
SnaA, that is reported to acetylate certain S-alkylcysteine
adducts such as S-methylcysteine (26). An snaA deletant grew
well on 2SC; however, a mutant lacking both acetyltransferase
genes yxeL and snaA showedno sign of growth on 2SC (Fig. 3B),
indicating that an acetylation step is critical for 2SCmetabolism
and that snaA can partially compensate for yxeL deficiency.
Besides yxeP, B. subtilis has two other functionally redundant
N-acetylcysteine deacetylase genes, sndA and sndC (26). As was
observed for the yxeP deletant, mutants of sndA and sndC grew
Figure 1. Spontaneous reaction of fumarate with thiols. Succination
occurs when thiols (or more specifically, thiolate ions) of cysteine, cysteinyl
residues, GSH, or other compounds react with fumarate to form stable
S-(2-succino)-derivatives.
Figure 2. Tn-seq indicates that the yxeKLMNOPQoperon is important for
SSC breakdown in B. subtilis. Tn-seq was performed on a library of random
transposon insertion mutations in B. subtilis grown for six doublings in
defined medium containing either 2 mM sulfate (SO4), 1 mM L-methionine
(Met), or 1 mM 2SC as the sole sulfur source. Each histogram shows the loca-
tion and relative frequency of transposon insertions in the indicated genome
region. The yxeKLMNOPQ operon is colored blue in the gene model and
shaded blue in the histograms. Data for the two genes flanking each side of
the yxeKLMNOPQ operon (uncolored in the gene model and histograms) are
shown for comparison.
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well on 2SC. However, a mutant lacking all three deacetylase
genes did not grow on 2SC (Fig. 3B). These results suggest that
a pathway to metabolize 2SC to cysteine involves acetylation
and deacetylation steps, similar to a proposed pathway for the
degradation of other S-alkylcysteine adducts (26).
Three monooxygenase genes, cmoO, cmoI, and cmoJ, have
all been reported to be essential for the degradation of
S-methylcysteine and other S-alkylcysteine adducts (26).
Mutants of each of these genes grew well on 2SC (Fig. 3C),
indicating that, apart from the acetylation and deacetylation
steps, the breakdown of 2SC requires distinct genes from
that of S-methylcysteine.
YxeL is a highly efficient 2SC N-acetyltransferase
Tn-seq and growth experiments indicate that the acetyl-
transferase gene yxeL is important for 2SC metabolism, but
growth tests show that snaAmay partially compensate for yxeL.
To test their relative ability to acetylate 2SC, we purified heter-
ologously expressed YxeL and SnaA proteins and assayed their
2SC N-acetyltransferase activity. YxeL could acetylate essen-
tially all the 2SC present in the assay mixture, indicating that it
acts on both diastereomers of 2SC, which should be present in
equimolar amounts (1, 2). The Km for YxeL is in the lowmicro-
molar range, which is more than 50-fold lower than that for
SnaA (Table 1). The turnover number for YxeL is more than
250-fold higher than that for SnaA, making YxeL about 13,000-
fold more catalytically efficient (Table 1). This fits with the Tn-
seq and growth data that indicate that yxeL is far more impor-
tant than snaA for 2SC metabolism. These kinetic parameters
are consistent with 2SC being a physiological substrate for
YxeL.
YxeL alleviates 2SC toxicity in B. subtilis by N-acetylation
YxeL is a highly efficient 2SC N-acetyltransferase and cata-
lyzes a critical step in 2SC metabolism. Acetylation of toxic or
unwanted compounds is a common strategy used by bacteria
(28), raising the possibility that YxeL alleviates 2SC toxicity. To
assess this, we tested whether 2SC inhibits growth of a B. sub-
tilis yxeL mutant. Wildtype (WT) or yxeL deletant cells were
overlaid on a plate containing sulfate as the sulfur source, and
2SC was added to the center of the plate. 2SC caused a zone of
growth inhibition to occur on yxeL deletant but notWT B. sub-
tilis, whereas N-acetyl-S-(2-succino)cysteine (N-acetyl-2SC)
did not inhibit growth of either strain (Fig. 4). These data indi-
cate that 2SC is a toxic compound, at least in B. subtilis at high
exogenous concentrations, and that N-acetylation relieves
toxicity.
Metabolite profiling confirms a breakdown pathway
Our data indicate that the first step in 2SC breakdown is
N-acetylation and that oxygenation and deacetylation steps are
also required. A reasonable scenario involves acetylation of 2SC
followed by oxygenation of N-acetyl-2SC and formation of
N-acetylcysteine (NAC), which is deacetylated to give cysteine,
analogous to the proposed breakdown pathway of other S-al-
kylcysteine compounds (26). If this proposed pathway for 2SC
deconstruction is correct, then mutants should accumulate
their respective upstream pathway intermediates.
The first step in the pathway is acetylation of 2SC. Thus, we
predicted that acetyltransferase (e.g. yxeL)mutantswould accu-
mulate 2SC. We profiled B. subtilis cells grown on medium
containing fumarate as the carbon source in an attempt to
increase the spontaneous succination of thiols by fumarate,
thereby increasing 2SC formation. 2SC was detected in both
WT and snaA deletant cells, but yxeL deletants accumulated
around 70-fold more 2SC (Fig. 5A). There was no significant
difference in 2SC levels between the yxeL deletant and yxeL
snaA doublemutant cells (Fig. 5A). These data confirm that the
yxeL gene product is the main enzyme controlling 2SC levels in
vivo.
We proposed that YxeK is a monooxygenase that acts
on N-acetyl-2SC. Thus, yxeK mutants should accumulate
N-acetyl-2SC.We profiled B. subtilis cells grown onmedium
Figure 3. Growth of various B. subtilismutants on 2SC.WT B. subtilis and
yxe operon gene knockouts (A), various acetyltransferase and deacetylase
mutants (B), and variousmonooxygenasemutants (C) were grown overnight
in LB medium with the appropriate antibiotic; washed twice with water; and
diluted to optical density 100, 101, 102, and 103, and 10l was spotted on
mediumwith either 1mM 2SC or 2mM sulfate as the sulfur source. Incubation
was for 16 h at 37 °C.
Table 1
Kinetic properties of recombinant YxeL and SnaA proteins
Activities were determined at 37 °C as described under “Experimental procedures.”
Values are means and S.E. of three replicates.
Protein Km Kcat Kcat/Km
M s1 mM1s1
YxeL 86.4 1.6 9.5 0.6 110
SnaA 4380 240 0.037 0.001 0.0084
Deconstruction of the oncometabolite S-(2-succino)cysteine
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containing glucose as the carbon source but were unable to
detect N-acetyl-2SC in WT or yxeK deletant cells (Fig. 5B). In
an attempt to force carbon flux through the 2SC breakdown
pathway, we added 2SC to the culture either 10 or 60 min prior
to harvesting the cells. When 2SC was added to the culture 10
min prior to harvesting, yxeK deletant cells showed a massive
accumulation of N-acetyl-2SC to around 8 mol mg1 of pro-
tein (Fig. 5B). By 60 min after 2SC addition, N-acetyl-2SC was
still readily detectable, but the levels decreased about 25-fold
compared with 10 min after 2SC addition (Fig. 5B). There was
also a small but significant increase in NAC at 60min after 2SC
addition (Fig. 5B). These data indicate that the yxeK gene prod-
uct plays a major role in the breakdown of 2SC by acting on
N-acetyl-2SC, likely giving rise to NAC. Because the levels of
N-acetyl-2SC decreased and NAC slightly increased between
10 and 60 min after 2SC addition to the mutant, there may be
one or more functionally redundant mechanisms that can par-
tially compensate for the loss of YxeK.
YxeP is predicted to be an NAC deacetylase that completes
the 2SC breakdown pathway. Because growth tests indicated
that B. subtilis has three functionally redundant NAC deacety-
lase genes (Fig. 3B), we profiled the triple mutant strain (yxeP
sndAC). Cells were grown in the same manner as the yxeK
deletants. There was no increase in NAC 10 min after addition
of 2SC, but there was a significant increase in N-acetyl-2SC
(Fig. 5C). At 60 min after 2SC addition, NAC levels increased
about 60-fold, andN-acetyl-2SC levels increased about 10-fold
comparedwith the values obtained at 10min after 2SC addition
(Fig. 5C). These data show that the levels of both upstream
intermediates, N-acetyl-2SC and NAC, increase in the NAC
deacetylase triple mutant and provide evidence in support of
the proposed pathway.
Discussion
Our results provide strong biochemical and genetic evidence
that genes of the yxe operon are primarily responsible for 2SC
breakdown inB. subtilis. The initial breakdown step isN-acety-
lation of 2SC, a reaction that YxeL performs remarkably well
(Table 1). The catalytic efficiency (Kcat/Km) of YxeL is 350-
fold higher than that of bacterial serine acetyltransferase, which
is another small-molecule acetyltransferase involved in cys-
teine metabolism (29). This high efficiency might be necessary
because of the toxicity of 2SC (Fig. 4) and thus the need to avoid
its accumulation. Our data show that the concentration of 2SC
is maintained below 5 M in B. subtilis cells (assuming a cell
volume of 4.6 fl (30)) unless yxeL is disrupted, evenwhen grown
under conditions that should favor an increase in succination
(Fig. 5A). In addition to initiating the salvage of cysteine from
2SC, YxeLmay also prevent the accumulation of a toxicmetab-
olite by converting it to a more benign form. If that were the
case, then yxeLwould fit the definition of ametabolite damage-
preemption gene (31).
The next step in 2SC breakdown, carried out by YxeK, is
likely oxygenation of the succinylmoiety ofN-acetyl-2SC, lead-
ing to the release ofNAC.One possiblemechanism for this step
is that YxeK hydroxylates the 2-position of the succinyl moiety
ofN-acetyl-2SC, causing a spontaneous elimination reaction of
the resulting hemithioketal that generates oxaloacetate and
NAC (Fig. 5D). Although other mechanisms are formally pos-
sible, the intermediate described above is analogous to the
hemithioacetal intermediate of the glyoxalase I reaction that is
formed from the reversible reaction of methyglyoxal with GSH
(32), so it is supported by a well-defined precedent. We were
unable to detect oxaloacetate in any bacterial sample; thus, we
cannot determine whether it accumulated in the cysteine
deacetylase triple mutant (yxeP sndAC) as our proposed
YxeK reaction schemes suggest it might (Fig. 5D). In any case,
further biochemical studies are needed to elucidate how YxeK
forms NAC from N-acetyl-2SC.
The last step in the pathway is deacetylation of NAC to give
cysteine.Our results show that deacetylation can occur byYxeP
or other functionally redundant NAC deacetylases (Figs. 3B
and 5C). Growth assays indicate that yxeM, yxeN, and yxeO,
which are predicted to encode the three subunits of an ABC-
type transporter, are not essential for 2SC utilization in B. sub-
tilis (Fig. 3A). Still, there is reason to suspect a 2SC transport
function for these genes. Our Tn-seq results show that trans-
poson insertions in these genes slightly decrease fitness
when grown on 2SC-containingmedium (Fig. 2). Furthermore,
B. subtilis has at least one other ABC-type transporter that has
been shown to transport sulfur-containing compounds, includ-
ing S-alkyl-derivatives of cysteine (33–36). yxeMNO genes may
encode a 2SC transporter that is not essential for growth on 2SC
in B. subtilis because of functional redundancy. Similarly, yxeQ
is not essential for 2SC utilization, but this could also be due to
functional redundancy. It is also possible that yxeQ allows the
yxe operon to participate in the disposal of compounds other
than 2SC.
Figure 4. 2SC is toxic toB. subtilisunless it isN-acetylated. Plates contain-
ingmediumwith 100M sulfate as the sulfur sourcewere overlaidwithWTor
yxeL B. subtilis cells, and a Whatman paper disc containing water () or 10
mol of the indicated compound was placed in the center of the plate. Pic-
tures were taken after 24-h incubation at 37 °C and are representative of four
independent experiments.
Deconstruction of the oncometabolite S-(2-succino)cysteine
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The 2SC breakdown pathway involves acetylation, oxygen-
ation-initiated deconstruction, and deacetylation, which is sim-
ilar to the pathway proposed for the metabolism of S-methyl-
cysteine, and the operons that are primarily used to metabolize
each compound (the yxe operon and ytmItcyJKLMNytmOytn
IJrbfKytnLM operon) are similar in content as noted previously
(26). This is likely the reason for the high degree of functional
redundancy observed between enzymes of each operon in the
breakdownof 2SC and S-methylcysteine. The deacetylases (and
probably ABC-type transporters) perform essentially the same
task and can efficiently moonlight in the breakdown of either
compound, whereas the acetyltransferases and monooxyge-
nases performmore specialized tasks and have a limited ability
to moonlight. Based on our evidence that the yxe operon is
predominantly responsible for 2SC breakdown, we propose
renaming it as the S-(2-succino)cysteine metabolism (scm)
operon.
To our knowledge, this is the first demonstration of a meta-
bolic route for 2SC breakdown. It was previously reported that
succinated GSH is a substrate of GSH reductase (37). How-
ever, these results are almost certainly artifactual because (a)
dimethyl fumarate was used instead of fumarate to succinate
GSH, (b) a mixture of dimethyl fumarate and GSH was assayed
instead of purified substrate, and (c) the reaction GSH reduc-
tase catalyzes, reduction of a disulfide bond, is different from
the hydrolysis reaction needed to break the thioether bond of
succinated GSH. Furthermore, we were unable to replicate
this finding in vitro with GSH reductase enzyme assays. The
expected enzyme activity was detected with GSH disulfide as a
substrate, but we could not detect any activity with purified
S-(2-succino)GSH, 2SC, or N-acetyl-2SC as substrates (Table
S1).
Although it is well-established that succination of cellular
thiols can have deleterious effects in vivo (e.g. by inactivating
enzymes with functional cysteine residues (18–21)), this is the
first report that 2SC itself is toxic, at least to B. subtilis. Break-
down of 2SC may be an important way to deal with this
unavoidable and toxic product of metabolism, more so than as
a means to recycle a damaged metabolite. Acetylation appears
to be a common strategy for prokaryotes to manage toxic
and/or reactive compounds. Bacteria often have specific acetyl-
transferases that prevent the toxic buildup of sugars such as
lactose (38) and maltose (39, 40), and acetylation of antibiotics
is a common mechanism of bacterial resistance (41). 2SC dis-
posal substantiates the emerging paradigm that cells often han-
dle toxic metabolites by pathways that begin with acetylation
and end with deacetylation in direct analogy to the blocking–
deblocking strategies used in organic chemistry (26).
Figure 5. Accumulationof 2SC,N-acetyl-2SC, andNAC in variousB. subtilismutants supports a proposedbreakdownpathway.A, accumulation of 2SC
inWT B. subtilis andsnaA,yxeL, andsnaAyxeLmutant cells grown onminimalmedium containing fumarate as the carbon source. B and C, accumulation
ofN-acetyl-2SC andNAC inyxeK (B) andyxePsndAC (C) cells grown onminimalmedium containing glucose as the carbon sourcewithout (No 2SC) or with
the addition of 2SC to 0.5 mM either 10 (2SC 10) or 60 min (2SC 60) before harvesting the cells. Data represent means and S.E. (error bars) of three replicates.
Asterisks denote levels that are significantly different (*, p 0.05; ***, p 0.001; t test). †, not detectable (detection limit, 0.1 nmolmg1 protein).D, proposed
breakdown pathway for 2SC in B. subtilis. A possible reaction mechanism for YxeK as discussed in the text is shown. Solid or dotted lines indicate enzyme-
catalyzed or spontaneous reactions, respectively.
Deconstruction of the oncometabolite S-(2-succino)cysteine
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The yxe operon occurs in widely taxonomically diverse bac-
teria (Fig. S3), but the total number of species containing this
operon is quite small. Of a representative set of over 1600
diverse bacterial genomes (see “Experimental procedures”), the
yxe operon (defined as containing the monooxygenase and at
least two of the acetyltransferase, deacetylase, putative dehy-
dratase, and ABC transporter subunits) occurs in only 21.
Homologs of the monooxygenase gene yxeK, which is the most
distinct gene in the pathway and perhaps an indicator for the
ability to breakdown 2SC, are found outside of the context of
the yxe operon but are still limited to Bacteria, Archaea, and
Ascomycota fungi. Because succination of thiols is likely to
occur nearly ubiquitously, this raises the possibility that other
distinct 2SC breakdown pathways exist. It is also possible that
most organisms do not metabolize 2SC but instead simply
excrete it. If this were the case, then having a breakdown path-
way would enable the utilization of 2SC that has been released
to the environment.
Humans lack homologs of the yxe genes, and it is so far
unknownwhether they have a pathway tometabolize 2SC. Our
work provides an example of how such a pathway could oper-
ate. Considering the importance of succination to the progres-
sion of diseases such as diabetes (15–17, 42) and, in general, of
the role spontaneous modifications of macromolecules is
thought to play in aging (43), the identification of amammalian
system tometabolize 2SC, or otherwise deal with 2SC accumu-
lation, could provide important medical insights.
Experimental procedures
Bioinformatics
DNAand protein sequences were fromGenBankTM or SEED
(44). A representative set of 1641 bacterial and archaeal
genomes was analyzed using SEED tools (44). The yxe operon
consists of seven genes: yxeK (UniProt ID P54950), yxeL (Uni-
Prot ID P54951), yxeMNO (UniProt IDs P54952, P54953, and
P54954), yxeP (UniProt ID P54955), and yxeQ (UniProt ID
P54956).
Chemicals
2SC was made by combining 40 mmol of cysteine with 45
mmol of sodium fumarate in 50ml of water, adjusting pH to 8.0
with NaOH, and incubating at 22 °C for 35 h with stirring. The
mixture was lyophilized, and the resulting crystals were stored
at 20 °C. 2SC was further purified by HPLC using a Hypersil
GOLD 250 4.6-mmC18 column (Fisher Scientific) with 0.1%
formic acid as the mobile phase (flow rate, 1.0 ml min1). Frac-
tions containing 2SC (detected by absorbance at 210 nm) were
collected, and successive runs were pooled, lyophilized, and
stored at 20 °C. S-(2-Succino)GSH and N-acetyl-2SC were
synthesized and purified in the same manner except that 8
mmol of GSH and 9 mmol of sodium fumarate were combined
in 15 ml of water or 8 mmol ofN-acetyl-L-cysteine and 9 mmol
of sodium fumarate were combined in 12 ml of water, respec-
tively. All other chemicals were from Sigma-Aldrich.
Bacterial strains and culture conditions
All strains are listed in Table S2. All BKE mutant loci were
back-crossed into WT B. subtilis 168 by transforming 5 g of
isolatedDNA intoWTcells (45) and selecting for recombinants
on LB agar plates containing 1gml1 erythromycin and 25g
ml1 lincomycin. The presence of the BKE cassette in the
expected locus was verified (Fig. S5). The B. subtilis transposon
library used for Tn-seq experiments was described previously
(25). For growth assays and preparing Tn-seq and metabolite
profiling samples, strains were grown in ED minimal medium
(8 mM K2HPO4, 4.4 mM KH2PO4, 30 mMNH4Cl, 2 mMMgSO4,
0.6 mM MgCl2, 27 mM glucose, 0.3 mM Na3-citrate, 0.25 mM
L-tryptophan, 0.1 mM FeCl3, 50 M CaCl2, 5 M MnCl2, 12 M
ZnCl2, 2.5 M CuCl2, 2.5 M CoCl2, and 2.5 MNa2MoO4). To
prepare medium with 1 mM 2SC or methionine as the sulfur
source (or for medium with no sulfur), MgSO4 was replaced
with MgCl2 at the same magnesium concentration (2 mM).
Solid medium was prepared by adding low-melt agarose to a
final concentration of 0.8% (w/v). Growth assays were per-
formed as indicated. To prepare samples for Tn-seq, 0.4 ml of
the B. subtilis transposon library (stored at80 °C at an optical
density (600 nm) of 1.0) was combined with 7.6 ml of LB
medium and incubated at 37 °C with shaking for 1.5 h until
optical density reached 0.38. The library was thenwashed twice
in ED minimal medium (without sulfur) and used to inoculate
20 ml of ED medium or ED medium containing either 2 mM
sulfate, 1 mM Met, or 1 mM 2SC to an optical density of 0.02.
Cultures were incubated at 37 °C with shaking for 9–10 h until
optical density reached 1.3 (six doublings) at which point the
cells were harvested by centrifugation (8000  g, 10 min), fro-
zen in liquidN2, and stored at80 °C. For preparingmetabolite
profiling samples, glucose was replaced with 30 mM sodium
fumarate (when indicated). Overnight cultures were used to
inoculate fresh medium to an optical density of 0.05, and cul-
tures were grown at 37 °C with shaking for 6–8 h until optical
density reached 1.5 0.1 at which point an equivalent of 2ml at
optical density of 1.0 was harvested by centrifugation (21,000
g, 30 s), frozen in liquid N2, and stored at 80 °C. When indi-
cated, 2SC was added to a final concentration of 0.5 mM either
10 min or 1 h before harvesting.
Tn-seq analysis
Tn-seq was performed essentially as described previously
(25, 46). DNAwas isolated from the harvested cell pellets using
the GeneJET Genomic DNA Purification kit (Thermo Scien-
tific, Waltham,MA). 6 g of DNAwas treated with the restric-
tion enzymeMmeI (New England Biolabs, Ipswich,MA) for 3 h
at 37 °C, then 10 units of calf intestine phosphatase (New Eng-
land Biolabs) was added, and incubation was continued for 1 h.
The DNA was then extracted and precipitated (25) and dis-
solved in 27.5 l of 2 mM Tris-Cl, pH 8.5. To the DNA was
added 2 l of annealed DNA adapter (200 mM each of oCJ25
and oCJ26 oligonucleotides prepared as described (25)), 3.5 l
of 10T4 DNA ligase buffer, and 1.5 l (600 units) of T4 DNA
ligase (New England Biolabs). The ligation mixture was incu-
bated for 16 h at 16 °C, andDNAwas isolatedwith theGeneJET
Genomic DNA Purification kit. 5 l of adapter-ligated DNA
was used in PCRs with the oCJ23 primer and either primer
oCJ22-2 (sulfate-grown sample), oCJ22-4 (methionine-grown
sample), or oCJ22-6 (2SC-grown sample) as described previ-
ously (25). PCR products were electrophoresed on 2% agarose
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gels, the 128-bp band of interest was excised, and the DNA
was recovered in 15 l of 10 mM Tris-Cl, pH 8.5, with a DNA
Gel Extraction Mini kit (Qiagen, Hilden, Germany). Sequenc-
ing was performed at the University of Florida NextGen DNA
Sequencing facility (University of Florida Interdisciplinary
Center for Biotechnology Research). Using the oCJ24 oligonu-
cleotide to obtain the primary sequence and oCJ27 oligonucle-
otide to obtain the barcode sequences, we first used a MiSeq
system (Illumina, SanDiego, CA) for 1 50 cycles to determine
how much to load for optimum clustering. Sequencing was
then performed for 50 cycles with a NextSeq 500 (Illumina)
using a 1  75 high-throughput v2 cartridge. Custom primers
(25) were added to the standard Illumina primers to allow for
use of PhiX (10%). Approximately 320 million “passing-filter”
reads were generated per run. The data were trimmed with
Illumina software to remove everything except the 16–17-bp
region corresponding to the transposon–genome junctions.
Transposon insertion sites were mapped in the B. subtilis
reference genome sequence (NC_000964.3) using 16-mer
sequence tags. k-mer profiles (16-mer) were generated for
sequence data sets from each of the three treatments, SO4,Met,
and 2SC, using the count function of JELLYFISH (47). The
k-mer count profiles were then queried with the reference
genome sequence using the query function of JELLYFISH to
determine relative frequencies and genome coordinates of
insertions for each treatment. Insertion coordinates were then
overlaidwith the genome annotation (AL009126.gff) to identify
genes that were differentially targeted in the three data sets.
E. coli expression constructs
All constructs were sequence-verified. Full-length cDNAs
for B. subtilis YxeL (UniProt ID P54951) and SnaA (UniProt ID
O34350) were PCR-amplified from genomic DNA of B. subtilis
strain 168 with Phusion High-Fidelity DNA polymerase (New
England Biolabs) using primer pair 5-ggaattccatatgaagccac-
gataccgccttgc-3 and 5-ggaattcttatagatcatgtcgcaattgttt-3 and
primer pair 5-ggaattccatatgagtgatgatatttttcgactggc-3 and
5-ggaattctcatgcccagctgggcgcac-3, respectively. The amplified
DNAs were digested with NdeI/EcoRI and ligated into the
matching sites of pET28b (Novagen), which added anN-termi-
nal His6 tag.
Production and purification of proteins
The pET28b plasmids containing the snaA or yxeL coding
sequences were transformed into BL21-(DE3)-RIPL (Strat-
agene) cells. Cultures (100 ml) were grown at 37 °C in LB
mediumcontaining 50g/ml kanamycin.Whenoptical density
reached 0.8, isopropyl -D-thiogalactoside was added (final
concentration, 0.5mM), and incubationwas continued for 3 h at
37 °C. Cells were harvested by centrifugation (8000  g, 10
min); resuspended in 5 ml of 50 mM potassium phosphate, pH
8.0, 300 mM NaCl, and 10 mM imidazole; and sonicated (Fisher
Scientific Ultrasonic Dismembrator, model 150E) for 5 15-s
pulses at 70% power, cooling on ice for 60 s between pulses. The
lysate was centrifuged at 17,000 g for 10 min, and the super-
natant was added to a column containing 0.25ml of Ni2	-nitri-
lotriacetic acid resin (Qiagen). After washing with 25 ml of 50
mM potassium phosphate, pH 8.0, 300 mM NaCl, and 20 mM
imidazole, proteins were eluted with 0.5 ml of this buffer con-
taining 250 mM imidazole and desalted on PD-10 columns (GE
Healthcare) equilibrated in 50 mM Tris-HCl, pH 8.0, 100 mM
KCl, 10% (v/v) glycerol. Proteins were concentrated to 3.5–8.0
mg ml1 with Amicon Ultra-4 10,000 units (Millipore), then
aliquoted, frozen in liquid N2, and stored at80 °C.
Enzyme assays
Purified SnaA and SnaB proteins were assayed for acetyl-
transferase activity against 2SC using Ellman’s reagent as
described previously (48, 49). Assays (50-l total volume) con-
tained 50mMTris-Cl, pH 7.5, 0.4 mM acetyl-CoA, and between
8.0 and 0.001 mM 2SC and were started by adding either 8.8 g
of SnaAor 4.0 ng of SnaB.After a 10-min incubation at 37 °C, 50
l of a solution containing 50 mM Tris-Cl, pH 7.5, and 6 M
guanidineHCl was added to stop the reaction. 50l of Ellman’s
reagent (50 mM Tris-Cl, pH 7.5, 0.2 mM 5,5-dithiobis(2-nitro-
benzoic acid), and 1mMEDTA)was added, and themixturewas
incubated at 22 °C for 10 min before measuring optical density
at 412 nm. Assays were replicated at least three times. An
extinction coefficient of 14,150 cm1 M1 for 3-carboxy-4-ni-
trobenzenethiol was used to calculate the amount of CoA
formed. Kinetic parameters were calculated by fitting data to
the Michaelis–Menten equation using GraphPad Prism Soft-
ware (version 4.00 for Windows, GraphPad Software, San
Diego, CA).
Metabolic profiling
Extractions were performed essentially as described (50).
Briefly, 0.5 ml of ice-cold 80:20 (v/v) acetonitrile/water was
added to each sample and shaken at 4 °C for 15 min on an
orbital shaker (Torrey Pines Scientific) at maximum speed and
centrifuged at 14,000 g, and 0.5 ml of supernatant was trans-
ferred to a clean microcentrifuge tube. The extraction process
was repeated to give a total cell extract volume of 1ml. Aliquots
(0.2 ml) of the cell extract were dried under vacuum at room
temperature and frozen at 20 °C. For metabolic profiling,
samples were resuspended in 0.05 ml of acetonitrile/water (4:1,
v/v) containing internal standards (e.g. 5 g/ml Val-Tyr-Val). 5
l was injected onto a hydrophobic interaction LC column
(Waters AcquityUPLCBEHAmide, 150-mm length 2.1-mm
inner diameter, 1.7-m particle size) with guard column
(Acquity VanGuard BEH Amide precolumn, 5-mm length 
2.1-mm inner diameter, 1.7-mparticle size) held at 45 °C on a
Thermo Fisher Vanquish Focused ultra HPLC system. Mobile
phase A was LC-MS–grade water with 10 mM ammonium for-
mate and 0.125% formic acid. Mobile phase B was LC-MS–
grade 95:5 (v/v) acetonitrile/water with 10 mM ammonium for-
mate and 0.125% formic acid. Total run time per sample was 17
minwith a flow rate of 0.4ml/min. The gradient started at 100%
B for 2min; was brought to 70% B by 7.7 min, 40% B by 9.5 min,
and back to 100% B by 12.75 min; and then was held at 100% B
until 17 min. Mass spectra were recorded on a Thermo Fisher
Q-ExactiveHFmass spectrometer in positivemode between 60
and 900 m/z. Data were collected at resolutions of 60,000 for
MS1 and 15,000 forMS/MS.MS/MS informationwas collected
under data-dependent conditions for the top four ions perMS1
scan with one m/z isolation window and normalized collision
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energy of 20, 30, and 40. Automatic gain control target was set
at one million ions for MS1 and 150,000 ions for MS/MS. Cap-
illary temperaturewas set to 300 °C, spray voltagewas 3 kV, and
auxiliary gas flow rate was set to 20. S-(2-Succino)cysteine,
N-acetyl-2SC, and N-acetylcysteine standards were used to
identify and quantify thesemetabolites based on accuratemass,
retention time, andMS/MSmatching. Peak height was used for
quantification. For each standard, an MS/MS spectrum was
uploaded to the Mass Bank of North America (MONA) data-
base. Open source software MS-DIAL (51) was used for peak
deconvolution, peak picking, alignment, andMS/MSmatching.
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